HBK Sorce Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $914K | Buy |
8,507
+221
| +3% | +$23.7K | 0.02% | 236 |
|
|
2025
Q1 | $836K | Buy |
8,286
+254
| +3% | +$25.6K | 0.02% | 235 |
|
|
2024
Q4 | $717K | Sell |
8,032
-862
| -10% | -$77K | 0.02% | 268 |
|
|
2024
Q3 | $745K | Sell |
8,894
-212
| -2% | -$17.8K | 0.02% | 261 |
|
|
2024
Q2 | $701K | Sell |
9,106
-1,313
| -13% | -$101K | 0.02% | 266 |
|
|
2024
Q1 | $714K | Buy |
+10,419
| New | +$714K | 0.03% | 265 |
|
|
2023
Q4 | – | Sell |
-11,474
| Closed | -$606K | – | 571 |
|
|
2023
Q3 | $606K | Sell |
11,474
-119
| -1% | -$6.28K | 0.03% | 278 |
|
|
2023
Q2 | $627K | Buy |
11,593
+320
| +3% | +$17.3K | 0.03% | 278 |
|
|
2023
Q1 | $564K | Buy |
11,273
+4,669
| +71% | +$234K | 0.03% | 300 |
|
|
2022
Q4 | $306K | Buy |
+6,604
| New | +$306K | 0.01% | 557 |
|
|
2019
Q2 | – | Sell |
-5,767
| Closed | -$221K | – | 416 |
|
|
2019
Q1 | $221K | Hold |
5,767
| – | – | 0.02% | 394 |
|
|
2018
Q4 | $204K | Buy |
+5,767
| New | +$204K | 0.02% | 354 |
|